We consolidate our presence in Slovenia through continuous investment in development and production capacity. We build a stimulating, competitive and supportive work environment. We strengthen our role as a catalyst for the development of the pharmaceutical industry in Slovenia.
Read key business and development news in our company and various activities that we support and co-create. You can also browse the news archives dating back to 1998, our photo library and visual identity. For additional information, you can write to us at info.lek@sandoz.com.
Once again and for the third time in a row, Lek has been chosen as the most reputable employer in Slovenia according to the ...
In September, our organization joined the network of dementia-friendly institutions, with all four of our sites (Ljubljana, Mengeš, Prevalje, and Lendava) becoming dementia-friendly spots. We ...
Lek, a part of Novartis, was awarded the 2021 Good Practice Award for employing disabled people by the Ministry of Labor, Family, Social Affairs, and ...
Chronic myeloid leukemia (CML) is a type of blood cancer.
Contact
Lek d.d.
Verovškova 57, 1526 Ljubljana, Slovenia
T: +386 1 580 21 11
F: +386 1 568 35 17
info.lek@sandoz.com
VAT No.: SI87916452
Registration number: 1732811000
Nominal capital: 48.402.003,00 EUR